| Literature DB >> 25566512 |
Tanja Petnicki-Ocwieja1, Aurelie Kern1.
Abstract
Lyme disease is a long-term infection whose most severe pathology is characterized by inflammatory arthritis of the lower bearing joints, carditis, and neuropathy. The inflammatory cascades are initiated through the early recognition of invading Borrelia burgdorferi spirochetes by cells of the innate immune response, such as neutrophils and macrophage. B. burgdorferi does not have an intracellular niche and thus much research has focused on immune pathways activated by pathogen recognition molecules at the cell surface, such as the Toll-like receptors (TLRs). However, in recent years, studies have shown that internalization of the bacterium by host cells is an important component of the defense machinery in response to B. burgdorferi. Upon internalization, B. burgdorferi is trafficked through an endo/lysosomal pathway resulting in the activation of a number of intracellular pathogen recognition receptors including TLRs and Nod-like receptors (NLRs). Here we will review the innate immune molecules that participate in both cell surface and intracellular immune activation by B. burgdorferi.Entities:
Keywords: Borrelia burgdorferi; Lyme disease; Nod-like receptor signaling; Toll-like receptor signaling; endosomal signaling; phagocytosis
Mesh:
Year: 2014 PMID: 25566512 PMCID: PMC4266086 DOI: 10.3389/fcimb.2014.00175
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Extracellular and intracellular signaling pathways mediated by . Overview of the pathogen recognition receptors (PRRs) involved in the recognition and signaling in response to B. burgdorferi. Cell surface signaling is primarily mediated by TLR2/1 leading to pro-inflammatory cytokine production. Integrins and CD14 are known to recognize and internalize the spirochete but their role in intracellular signaling is not fully understood. Intracellular receptors located at the endosome, in particular TLR2/1, TLR7/8, and TLR9, are activated by different B. burgdorferi ligands and recruit adaptors such as MyD88 and/or TRIF to transduce signals for the activation of inflammatory cytokines and type I IFNs. The Nod2 receptor also plays a role in recognition of B. burgdorferi and in the induction of inflammatory responses, but it might have a dual regulatory role depending on the stage of infection. The inflammasome is likely to be involved, however, in vivo, it is unclear whether the inflammasome is required for the development of host responses to the pathogen.